HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence

Clinical trial NCT06812039 · RECRUITING

Trial details

NCT number: NCT06812039
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepato Cellular Carcinoma (HCC)

Start date: 2025-01-01
Primary completion: 2026-12-31
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.